Cargando…
Cellular Immune Response after Vaccination in Patients with Cancer—Review on Past and Present Experiences
Patients with cancer are at particular risk for infection but also have diminished vaccine responses, usually quantified by the level of specific antibodies. Nonetheless, vaccines are specifically recommended in this vulnerable patient group. Here, we discuss the cellular part of the vaccine respons...
Autores principales: | Rüthrich, Maria Madeleine, Giesen, Nicola, Mellinghoff, Sibylle C., Rieger, Christina T., von Lilienfeld-Toal, Marie |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8875094/ https://www.ncbi.nlm.nih.gov/pubmed/35214642 http://dx.doi.org/10.3390/vaccines10020182 |
Ejemplares similares
-
Impfung gegen SARS-CoV-2 bei Krebspatienten
por: von Lilienfeld-Toal, Marie, et al.
Publicado: (2021) -
2021 update of the AGIHO guideline on evidence-based management of COVID-19 in patients with cancer regarding diagnostics, viral shedding, vaccination and therapy
por: Giesen, Nicola, et al.
Publicado: (2021) -
Evidence-based management of COVID-19 in cancer patients: Guideline by the Infectious Diseases Working Party (AGIHO) of the German Society for Haematology and Medical Oncology (DGHO)
por: Giesen, Nicola, et al.
Publicado: (2020) -
AGIHO guideline on evidence-based management of COVID-19 in cancer patients: 2022 update on vaccination, pharmacological prophylaxis and therapy in light of the omicron variants
por: Giesen, Nicola, et al.
Publicado: (2023) -
Parainfluenza virus infections in patients with hematological malignancies or stem cell transplantation: Analysis of clinical characteristics, nosocomial transmission and viral shedding
por: Tabatabai, Julia, et al.
Publicado: (2022)